NYSE: AMEAmetek Inc Stock
$169.63+1.10 (+0.65%)
Updated May 15, 2024
AME Price
$169.63
Fair Value Price
N/A
Market Cap
$39.26B
52 Week Low
$136.89
52 Week High
$186.33
P/E
29.6x
P/B
4.38x
P/S
6.28x
PEG
4.54x
Dividend Yield
0.61%
Revenue
$6.74B
Earnings
$1.32B
Gross Margin
35.6%
Operating Margin
25.31%
Profit Margin
19.6%
Debt to Equity
0.66
Operating Cash Flow
$2B
Beta
1.05
Next Earnings
N/A
Ex-Dividend
Jun 14, 2024
Next Dividend
Jun 28, 2024
AME Overview
Ametek, Inc. manufactures electronic instruments and electromechanical devices. The company's original name, American Machine and Metals, was changed to AMETEK in the early 1960s, reflecting its evolution from the manufacture of heavy machinery to analytical instruments, precision components, and specialty materials. Ametek offers over 100 brands of monitoring, testing, and calibration devices as well as electrical motors, pumps, and interconnects. The company was founded in 1930 and is headquartered in Berwyn, PA.
Zen Score
–
Industry Average (35)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AME scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AME ($169.63) is trading above its intrinsic value of $44.52, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AME is good value based on its earnings relative to its share price (29.6x), compared to the US market average (31.36x)
P/E vs Market Valuation
AME is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more AME due diligence checks available for Premium users.
Be the first to know about important AME news, forecast changes, insider trades & much more!
AME News
Valuation
AME price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.6x
Industry
24.44x
Market
31.36x
AME is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AME is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
AME price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.38x
Industry
5.25x
AME is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AME price to earnings growth (PEG)
For valuing profitable companies with growth potential
AME is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AME's financial health
Profit margin
Revenue
$1.7B
Net Income
$310.9M
Profit Margin
17.9%
AME's Earnings (EBIT) of $1.70B... subscribe to Premium to read more.
Interest Coverage Financials
AME's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.9B
Liabilities
$5.9B
Debt to equity
0.66
AME's short-term assets ($2.78B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AME's long-term liabilities ($3.39B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AME's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AME's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$410.2M
Investing
-$21.4M
Financing
-$417.5M
AME's operating cash flow ($1.76B)... subscribe to Premium to read more.
Debt Coverage Financials
AME vs Specialty Industrial Machinery Stocks
Ametek Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.